This inventor holds 35 USPTO granted patents, plus 1 CIPO patent and 9 EPO patents, primarily in HSP90 Inhibitors. Top assignees: Synta Pharmaceuticals Corporation, Houston Pharmaceuticals, Inc., The University of Texas System. Active years: 1999-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- The Woodlands, TX (US) (1999)
- Acton, MA (US) (2002 - 2004)
- Burlington, MA (US) (2003 - 2006)
- Tewksbury, MA (US) (2004 - 2015)
Company Filing History:
30 out of 162 
2 out of 3 
2 out of 5,644 
Years Active: 1999-2015
Areas of Expertise:
Title: Teresa Przewloka: Innovator in Triazole Compounds
Introduction: Teresa Przewloka is an accomplished inventor based in Tewksbury, Massachusetts. With an impressive portfolio of 35 patents, she has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have the potential to address critical health issues such as cancer.
Latest Patents: Among her latest innovations are the triazole compounds that modulate HSP90 activity. These inventions involve substituted triazole compounds and compositions that aim to inhibit the activity of Hsp90 in subjects requiring treatment. Furthermore, these methods target the prevention or treatment of hyperproliferative disorders like cancer, showcasing the therapeutic potential of her discoveries.
Career Highlights: Teresa has had a thriving career in pharmaceutical research, with pivotal roles in companies including Synta Pharmaceuticals Corporation and Houston Pharmaceuticals, Inc. Her work has been instrumental in advancing drug development and addressing complex medical challenges.
Collaborations: During her career, Teresa has collaborated with talented professionals such as Lijun Sun and Weiwen Ying. These partnerships underscore the importance of teamwork and innovation in the research and development of new therapeutic solutions.
Conclusion: Teresa Przewloka stands out as a driving force in the pharmaceutical industry, particularly through her innovative work with triazole compounds. With a wealth of patents and a commitment to improving therapeutic options for patients, her contributions are noteworthy and continue to make an impact in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile